The info on clinicaltrials.gov is often badly out of date. For instance, the entry for the MM-093 trial in psoriasis hasn’t been updated since 11/05. (It indicates that the trial is still recruiting, even though we know it ended in 2006.)
Thanks to the sleuthing by floblu, we know that Merrimack plans to report the data from both MM-093 trials at the EULAR conference in June.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.